These data suggest correlations between Ca2+ mobilization and muscle performance phenotypes in dystrophic myotubes, and modulation of Orai1–STIM1 activity may be a potent target to ameliorate the contractile phenotypes in DMD. The gene discussed is STIM1; the disease is Duchenne muscular dystrophy.